Scientific Reports-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2260558, encodeId=0e452260558d2, content=投稿命中率:75.0 经验分享：二审5个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=075a9469484, createdName=ms2000001485045977, createdTime=Tue Apr 15 13:48:25 CST 2025, time=昨天, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2246458, encodeId=1f582246458f2, content=偏重的研究方向：临床 经验分享：投稿3个月被拒，投稿十天分配编辑，邀请审稿人三天后第一份意见收到，之后3个月一直等第二份审稿意见。最后，两个审稿人意见都很好，最后编辑给拒稿了。邮件末尾一看，编辑还是中国人，搞不懂为啥拒稿啊，意见都挺好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=142c9446281, createdName=ms4000002102138234, createdTime=Sat Jan 04 00:00:01 CST 2025, time=2025-01-04, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2259287, encodeId=111d225928ebf, content=审稿速度:6.0 偏重的研究方向：临床 经验分享：投稿5个月了，在2024年11月Reviewer report(s) received后就没有下文了，催了两次都没收到回复，大家催稿联系的是这个邮箱吗？srep@nature.com. Submission history Submission received Submission status Date Submission received 30 Oct 2024 Technical check Submission status Date Submission is under technical check 30 Oct 2024 Amendment requested 13 Nov 2024 Amendment received 13 Nov 2024 Amendment requested 14 Nov 2024 Amendment received 14 Nov 2024 Amendment requested 15 Nov 2024 Amendment received 15 Nov 2024 Submission passed technical check 15 Nov 2024 Editorial assignment Submission status Date Ready for editorial assignment 15 Nov 2024 With editor Submission status Date Editor assigned 25 Nov 2024 Peer review Submission status Date First reviewer(s) invited 25 Nov 2024 Reviewer(s) accepted 25 Nov 2024 Reviewer report(s) received 30 Nov 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0ef1674859, createdName=冰冷仙境, createdTime=Sat Apr 05 23:07:59 CST 2025, time=2025-04-05, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2257896, encodeId=f12c225e89678, content=偏重的研究方向：生信 经验分享：<a href='/topic/show?id=8aca1253863a' target=_blank style='color:#2F92EE;'>#NHANES数据库#</a> 3.1提交 3.6技术审核通过 3.6到现在已经过去20天，显示Ready for editorial assignment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=4, topicName=null, topicId=null, topicList=[TopicDto(id=125386, encryptionId=8aca1253863a, topicName=NHANES数据库)], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/ef17d3a0e1734e759d27ae31bfd577b4-6z81Fjps9u6c.jpeg, type=image, width=685, height=1410)], authenticateStatus=null, createdAvatar=null, createdBy=44a48378232, createdName=ms8000000780400336, createdTime=Wed Mar 26 23:42:08 CST 2025, time=2025-03-26, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2258357, encodeId=957a225835e35, content=投稿7个月，一直在with editor，期间第一次催，态度极好，第7个月再催，拒稿，没有任何意见。太耽误时间了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d171553686, createdName=tianjp506, createdTime=Sun Mar 30 10:50:28 CST 2025, time=2025-03-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2258171, encodeId=6b2622581e1ba, content=偏重的研究方向：医学;综合 经验分享：SR投稿已有半年，目前已邀请超过10个审稿人，只有两个审稿人接受了审稿，然而还没有一个审稿人报告返回。太慢了吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28145445823, createdName=小计划, createdTime=Fri Mar 28 17:00:07 CST 2025, time=2025-03-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2233207, encodeId=1ba9223320e12, content=我八月份投了一篇孟德尔，因为没有交STROBE-MR被撤回了。之后补了表二次提交，已经进入同行评审了，收到邮件“It appears that you have already submitted your manuscript before to scientific reports and it was rejected for STROBE-MR checklist issue. I am sorry to inform you that we can not consider such manuscripts again. ”。因为第一次的问题导致第二次被撤回了？有没有什么补救办法呀，都送审了。求问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53b28427490, createdName=多多放辣, createdTime=Fri Oct 25 23:42:10 CST 2024, time=2024-10-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2257178, encodeId=2755225e1786d, content=投稿命中率:50.0 经验分享：我投的纯生信送审了，但是我想问一下审稿人拒掉的概率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed8e9545535, createdName=ms3000001858569369, createdTime=Fri Mar 21 21:35:43 CST 2025, time=2025-03-21, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2229336, encodeId=de44222933682, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：第一轮三个审稿人提了20多个问题，修稿完后又重新邀请审稿人，这次四个审稿人审稿，大家也是有这么多吗，还一轮一轮的审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37235317227, createdName=1489e359m96(暂无昵称), createdTime=Sat Oct 05 08:21:22 CST 2024, time=2024-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2249606, encodeId=d1222249606d5, content=2025中科院分区有可能降回3区吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58d55497410, createdName=慢热型选手, createdTime=Sat Jan 25 17:00:13 CST 2025, time=2025-01-25, status=1, ipAttribution=河北省)]

昨天 ms2000001485045977 来自浙江省

投稿命中率:75.0
经验分享：二审5个月

3 0

[GetPortalCommentsPageByObjectIdResponse(id=2260558, encodeId=0e452260558d2, content=投稿命中率:75.0 经验分享：二审5个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=075a9469484, createdName=ms2000001485045977, createdTime=Tue Apr 15 13:48:25 CST 2025, time=昨天, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2246458, encodeId=1f582246458f2, content=偏重的研究方向：临床 经验分享：投稿3个月被拒，投稿十天分配编辑，邀请审稿人三天后第一份意见收到，之后3个月一直等第二份审稿意见。最后，两个审稿人意见都很好，最后编辑给拒稿了。邮件末尾一看，编辑还是中国人，搞不懂为啥拒稿啊，意见都挺好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=142c9446281, createdName=ms4000002102138234, createdTime=Sat Jan 04 00:00:01 CST 2025, time=2025-01-04, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2259287, encodeId=111d225928ebf, content=审稿速度:6.0 偏重的研究方向：临床 经验分享：投稿5个月了，在2024年11月Reviewer report(s) received后就没有下文了，催了两次都没收到回复，大家催稿联系的是这个邮箱吗？srep@nature.com. Submission history Submission received Submission status Date Submission received 30 Oct 2024 Technical check Submission status Date Submission is under technical check 30 Oct 2024 Amendment requested 13 Nov 2024 Amendment received 13 Nov 2024 Amendment requested 14 Nov 2024 Amendment received 14 Nov 2024 Amendment requested 15 Nov 2024 Amendment received 15 Nov 2024 Submission passed technical check 15 Nov 2024 Editorial assignment Submission status Date Ready for editorial assignment 15 Nov 2024 With editor Submission status Date Editor assigned 25 Nov 2024 Peer review Submission status Date First reviewer(s) invited 25 Nov 2024 Reviewer(s) accepted 25 Nov 2024 Reviewer report(s) received 30 Nov 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0ef1674859, createdName=冰冷仙境, createdTime=Sat Apr 05 23:07:59 CST 2025, time=2025-04-05, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2257896, encodeId=f12c225e89678, content=偏重的研究方向：生信 经验分享：<a href='/topic/show?id=8aca1253863a' target=_blank style='color:#2F92EE;'>#NHANES数据库#</a> 3.1提交 3.6技术审核通过 3.6到现在已经过去20天，显示Ready for editorial assignment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=4, topicName=null, topicId=null, topicList=[TopicDto(id=125386, encryptionId=8aca1253863a, topicName=NHANES数据库)], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/ef17d3a0e1734e759d27ae31bfd577b4-6z81Fjps9u6c.jpeg, type=image, width=685, height=1410)], authenticateStatus=null, createdAvatar=null, createdBy=44a48378232, createdName=ms8000000780400336, createdTime=Wed Mar 26 23:42:08 CST 2025, time=2025-03-26, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2258357, encodeId=957a225835e35, content=投稿7个月，一直在with editor，期间第一次催，态度极好，第7个月再催，拒稿，没有任何意见。太耽误时间了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d171553686, createdName=tianjp506, createdTime=Sun Mar 30 10:50:28 CST 2025, time=2025-03-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2258171, encodeId=6b2622581e1ba, content=偏重的研究方向：医学;综合 经验分享：SR投稿已有半年，目前已邀请超过10个审稿人，只有两个审稿人接受了审稿，然而还没有一个审稿人报告返回。太慢了吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28145445823, createdName=小计划, createdTime=Fri Mar 28 17:00:07 CST 2025, time=2025-03-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2233207, encodeId=1ba9223320e12, content=我八月份投了一篇孟德尔，因为没有交STROBE-MR被撤回了。之后补了表二次提交，已经进入同行评审了，收到邮件“It appears that you have already submitted your manuscript before to scientific reports and it was rejected for STROBE-MR checklist issue. I am sorry to inform you that we can not consider such manuscripts again. ”。因为第一次的问题导致第二次被撤回了？有没有什么补救办法呀，都送审了。求问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53b28427490, createdName=多多放辣, createdTime=Fri Oct 25 23:42:10 CST 2024, time=2024-10-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2257178, encodeId=2755225e1786d, content=投稿命中率:50.0 经验分享：我投的纯生信送审了，但是我想问一下审稿人拒掉的概率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed8e9545535, createdName=ms3000001858569369, createdTime=Fri Mar 21 21:35:43 CST 2025, time=2025-03-21, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2229336, encodeId=de44222933682, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：第一轮三个审稿人提了20多个问题，修稿完后又重新邀请审稿人，这次四个审稿人审稿，大家也是有这么多吗，还一轮一轮的审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37235317227, createdName=1489e359m96(暂无昵称), createdTime=Sat Oct 05 08:21:22 CST 2024, time=2024-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2249606, encodeId=d1222249606d5, content=2025中科院分区有可能降回3区吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58d55497410, createdName=慢热型选手, createdTime=Sat Jan 25 17:00:13 CST 2025, time=2025-01-25, status=1, ipAttribution=河北省)]

2025-01-04 ms4000002102138234 来自山西省

偏重的研究方向：临床
经验分享：投稿3个月被拒，投稿十天分配编辑，邀请审稿人三天后第一份意见收到，之后3个月一直等第二份审稿意见。最后，两个审稿人意见都很好，最后编辑给拒稿了。邮件末尾一看，编辑还是中国人，搞不懂为啥拒稿啊，意见都挺好的

31 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2260558, encodeId=0e452260558d2, content=投稿命中率:75.0 经验分享：二审5个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=075a9469484, createdName=ms2000001485045977, createdTime=Tue Apr 15 13:48:25 CST 2025, time=昨天, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2246458, encodeId=1f582246458f2, content=偏重的研究方向：临床 经验分享：投稿3个月被拒，投稿十天分配编辑，邀请审稿人三天后第一份意见收到，之后3个月一直等第二份审稿意见。最后，两个审稿人意见都很好，最后编辑给拒稿了。邮件末尾一看，编辑还是中国人，搞不懂为啥拒稿啊，意见都挺好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=142c9446281, createdName=ms4000002102138234, createdTime=Sat Jan 04 00:00:01 CST 2025, time=2025-01-04, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2259287, encodeId=111d225928ebf, content=审稿速度:6.0 偏重的研究方向：临床 经验分享：投稿5个月了，在2024年11月Reviewer report(s) received后就没有下文了，催了两次都没收到回复，大家催稿联系的是这个邮箱吗？srep@nature.com. Submission history Submission received Submission status Date Submission received 30 Oct 2024 Technical check Submission status Date Submission is under technical check 30 Oct 2024 Amendment requested 13 Nov 2024 Amendment received 13 Nov 2024 Amendment requested 14 Nov 2024 Amendment received 14 Nov 2024 Amendment requested 15 Nov 2024 Amendment received 15 Nov 2024 Submission passed technical check 15 Nov 2024 Editorial assignment Submission status Date Ready for editorial assignment 15 Nov 2024 With editor Submission status Date Editor assigned 25 Nov 2024 Peer review Submission status Date First reviewer(s) invited 25 Nov 2024 Reviewer(s) accepted 25 Nov 2024 Reviewer report(s) received 30 Nov 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0ef1674859, createdName=冰冷仙境, createdTime=Sat Apr 05 23:07:59 CST 2025, time=2025-04-05, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2257896, encodeId=f12c225e89678, content=偏重的研究方向：生信 经验分享：<a href='/topic/show?id=8aca1253863a' target=_blank style='color:#2F92EE;'>#NHANES数据库#</a> 3.1提交 3.6技术审核通过 3.6到现在已经过去20天，显示Ready for editorial assignment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=4, topicName=null, topicId=null, topicList=[TopicDto(id=125386, encryptionId=8aca1253863a, topicName=NHANES数据库)], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/ef17d3a0e1734e759d27ae31bfd577b4-6z81Fjps9u6c.jpeg, type=image, width=685, height=1410)], authenticateStatus=null, createdAvatar=null, createdBy=44a48378232, createdName=ms8000000780400336, createdTime=Wed Mar 26 23:42:08 CST 2025, time=2025-03-26, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2258357, encodeId=957a225835e35, content=投稿7个月，一直在with editor，期间第一次催，态度极好，第7个月再催，拒稿，没有任何意见。太耽误时间了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d171553686, createdName=tianjp506, createdTime=Sun Mar 30 10:50:28 CST 2025, time=2025-03-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2258171, encodeId=6b2622581e1ba, content=偏重的研究方向：医学;综合 经验分享：SR投稿已有半年，目前已邀请超过10个审稿人，只有两个审稿人接受了审稿，然而还没有一个审稿人报告返回。太慢了吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28145445823, createdName=小计划, createdTime=Fri Mar 28 17:00:07 CST 2025, time=2025-03-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2233207, encodeId=1ba9223320e12, content=我八月份投了一篇孟德尔，因为没有交STROBE-MR被撤回了。之后补了表二次提交，已经进入同行评审了，收到邮件“It appears that you have already submitted your manuscript before to scientific reports and it was rejected for STROBE-MR checklist issue. I am sorry to inform you that we can not consider such manuscripts again. ”。因为第一次的问题导致第二次被撤回了？有没有什么补救办法呀，都送审了。求问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53b28427490, createdName=多多放辣, createdTime=Fri Oct 25 23:42:10 CST 2024, time=2024-10-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2257178, encodeId=2755225e1786d, content=投稿命中率:50.0 经验分享：我投的纯生信送审了，但是我想问一下审稿人拒掉的概率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed8e9545535, createdName=ms3000001858569369, createdTime=Fri Mar 21 21:35:43 CST 2025, time=2025-03-21, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2229336, encodeId=de44222933682, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：第一轮三个审稿人提了20多个问题，修稿完后又重新邀请审稿人，这次四个审稿人审稿，大家也是有这么多吗，还一轮一轮的审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37235317227, createdName=1489e359m96(暂无昵称), createdTime=Sat Oct 05 08:21:22 CST 2024, time=2024-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2249606, encodeId=d1222249606d5, content=2025中科院分区有可能降回3区吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58d55497410, createdName=慢热型选手, createdTime=Sat Jan 25 17:00:13 CST 2025, time=2025-01-25, status=1, ipAttribution=河北省)]

2025-04-05 冰冷仙境来自河北省

审稿速度:6.0
偏重的研究方向：临床
经验分享：投稿5个月了，在2024年11月Reviewer report(s) received后就没有下文了，催了两次都没收到回复，大家催稿联系的是这个邮箱吗？srep@nature.com.
Submission history
Submission received
Submission status Date
Submission received
30 Oct 2024
Technical check
Submission status Date
Submission is under technical check
30 Oct 2024
Amendment requested
13 Nov 2024
Amendment received
13 Nov 2024
Amendment requested
14 Nov 2024
Amendment received
14 Nov 2024
Amendment requested
15 Nov 2024
Amendment received
15 Nov 2024
Submission passed technical check
15 Nov 2024
Editorial assignment
Submission status Date
Ready for editorial assignment
15 Nov 2024
With editor
Submission status Date
Editor assigned
25 Nov 2024
Peer review
Submission status Date
First reviewer(s) invited
25 Nov 2024
Reviewer(s) accepted
25 Nov 2024
Reviewer report(s) received
30 Nov 2024

6 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2260558, encodeId=0e452260558d2, content=投稿命中率:75.0 经验分享：二审5个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=075a9469484, createdName=ms2000001485045977, createdTime=Tue Apr 15 13:48:25 CST 2025, time=昨天, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2246458, encodeId=1f582246458f2, content=偏重的研究方向：临床 经验分享：投稿3个月被拒，投稿十天分配编辑，邀请审稿人三天后第一份意见收到，之后3个月一直等第二份审稿意见。最后，两个审稿人意见都很好，最后编辑给拒稿了。邮件末尾一看，编辑还是中国人，搞不懂为啥拒稿啊，意见都挺好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=142c9446281, createdName=ms4000002102138234, createdTime=Sat Jan 04 00:00:01 CST 2025, time=2025-01-04, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2259287, encodeId=111d225928ebf, content=审稿速度:6.0 偏重的研究方向：临床 经验分享：投稿5个月了，在2024年11月Reviewer report(s) received后就没有下文了，催了两次都没收到回复，大家催稿联系的是这个邮箱吗？srep@nature.com. Submission history Submission received Submission status Date Submission received 30 Oct 2024 Technical check Submission status Date Submission is under technical check 30 Oct 2024 Amendment requested 13 Nov 2024 Amendment received 13 Nov 2024 Amendment requested 14 Nov 2024 Amendment received 14 Nov 2024 Amendment requested 15 Nov 2024 Amendment received 15 Nov 2024 Submission passed technical check 15 Nov 2024 Editorial assignment Submission status Date Ready for editorial assignment 15 Nov 2024 With editor Submission status Date Editor assigned 25 Nov 2024 Peer review Submission status Date First reviewer(s) invited 25 Nov 2024 Reviewer(s) accepted 25 Nov 2024 Reviewer report(s) received 30 Nov 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0ef1674859, createdName=冰冷仙境, createdTime=Sat Apr 05 23:07:59 CST 2025, time=2025-04-05, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2257896, encodeId=f12c225e89678, content=偏重的研究方向：生信 经验分享：<a href='/topic/show?id=8aca1253863a' target=_blank style='color:#2F92EE;'>#NHANES数据库#</a> 3.1提交 3.6技术审核通过 3.6到现在已经过去20天，显示Ready for editorial assignment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=4, topicName=null, topicId=null, topicList=[TopicDto(id=125386, encryptionId=8aca1253863a, topicName=NHANES数据库)], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/ef17d3a0e1734e759d27ae31bfd577b4-6z81Fjps9u6c.jpeg, type=image, width=685, height=1410)], authenticateStatus=null, createdAvatar=null, createdBy=44a48378232, createdName=ms8000000780400336, createdTime=Wed Mar 26 23:42:08 CST 2025, time=2025-03-26, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2258357, encodeId=957a225835e35, content=投稿7个月，一直在with editor，期间第一次催，态度极好，第7个月再催，拒稿，没有任何意见。太耽误时间了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d171553686, createdName=tianjp506, createdTime=Sun Mar 30 10:50:28 CST 2025, time=2025-03-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2258171, encodeId=6b2622581e1ba, content=偏重的研究方向：医学;综合 经验分享：SR投稿已有半年，目前已邀请超过10个审稿人，只有两个审稿人接受了审稿，然而还没有一个审稿人报告返回。太慢了吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28145445823, createdName=小计划, createdTime=Fri Mar 28 17:00:07 CST 2025, time=2025-03-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2233207, encodeId=1ba9223320e12, content=我八月份投了一篇孟德尔，因为没有交STROBE-MR被撤回了。之后补了表二次提交，已经进入同行评审了，收到邮件“It appears that you have already submitted your manuscript before to scientific reports and it was rejected for STROBE-MR checklist issue. I am sorry to inform you that we can not consider such manuscripts again. ”。因为第一次的问题导致第二次被撤回了？有没有什么补救办法呀，都送审了。求问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53b28427490, createdName=多多放辣, createdTime=Fri Oct 25 23:42:10 CST 2024, time=2024-10-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2257178, encodeId=2755225e1786d, content=投稿命中率:50.0 经验分享：我投的纯生信送审了，但是我想问一下审稿人拒掉的概率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed8e9545535, createdName=ms3000001858569369, createdTime=Fri Mar 21 21:35:43 CST 2025, time=2025-03-21, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2229336, encodeId=de44222933682, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：第一轮三个审稿人提了20多个问题，修稿完后又重新邀请审稿人，这次四个审稿人审稿，大家也是有这么多吗，还一轮一轮的审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37235317227, createdName=1489e359m96(暂无昵称), createdTime=Sat Oct 05 08:21:22 CST 2024, time=2024-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2249606, encodeId=d1222249606d5, content=2025中科院分区有可能降回3区吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58d55497410, createdName=慢热型选手, createdTime=Sat Jan 25 17:00:13 CST 2025, time=2025-01-25, status=1, ipAttribution=河北省)]

2025-03-26 ms8000000780400336 来自重庆

精彩评论，需要您登录查看

10 4

[GetPortalCommentsPageByObjectIdResponse(id=2260558, encodeId=0e452260558d2, content=投稿命中率:75.0 经验分享：二审5个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=075a9469484, createdName=ms2000001485045977, createdTime=Tue Apr 15 13:48:25 CST 2025, time=昨天, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2246458, encodeId=1f582246458f2, content=偏重的研究方向：临床 经验分享：投稿3个月被拒，投稿十天分配编辑，邀请审稿人三天后第一份意见收到，之后3个月一直等第二份审稿意见。最后，两个审稿人意见都很好，最后编辑给拒稿了。邮件末尾一看，编辑还是中国人，搞不懂为啥拒稿啊，意见都挺好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=142c9446281, createdName=ms4000002102138234, createdTime=Sat Jan 04 00:00:01 CST 2025, time=2025-01-04, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2259287, encodeId=111d225928ebf, content=审稿速度:6.0 偏重的研究方向：临床 经验分享：投稿5个月了，在2024年11月Reviewer report(s) received后就没有下文了，催了两次都没收到回复，大家催稿联系的是这个邮箱吗？srep@nature.com. Submission history Submission received Submission status Date Submission received 30 Oct 2024 Technical check Submission status Date Submission is under technical check 30 Oct 2024 Amendment requested 13 Nov 2024 Amendment received 13 Nov 2024 Amendment requested 14 Nov 2024 Amendment received 14 Nov 2024 Amendment requested 15 Nov 2024 Amendment received 15 Nov 2024 Submission passed technical check 15 Nov 2024 Editorial assignment Submission status Date Ready for editorial assignment 15 Nov 2024 With editor Submission status Date Editor assigned 25 Nov 2024 Peer review Submission status Date First reviewer(s) invited 25 Nov 2024 Reviewer(s) accepted 25 Nov 2024 Reviewer report(s) received 30 Nov 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0ef1674859, createdName=冰冷仙境, createdTime=Sat Apr 05 23:07:59 CST 2025, time=2025-04-05, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2257896, encodeId=f12c225e89678, content=偏重的研究方向：生信 经验分享：<a href='/topic/show?id=8aca1253863a' target=_blank style='color:#2F92EE;'>#NHANES数据库#</a> 3.1提交 3.6技术审核通过 3.6到现在已经过去20天，显示Ready for editorial assignment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=4, topicName=null, topicId=null, topicList=[TopicDto(id=125386, encryptionId=8aca1253863a, topicName=NHANES数据库)], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/ef17d3a0e1734e759d27ae31bfd577b4-6z81Fjps9u6c.jpeg, type=image, width=685, height=1410)], authenticateStatus=null, createdAvatar=null, createdBy=44a48378232, createdName=ms8000000780400336, createdTime=Wed Mar 26 23:42:08 CST 2025, time=2025-03-26, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2258357, encodeId=957a225835e35, content=投稿7个月，一直在with editor，期间第一次催，态度极好，第7个月再催，拒稿，没有任何意见。太耽误时间了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d171553686, createdName=tianjp506, createdTime=Sun Mar 30 10:50:28 CST 2025, time=2025-03-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2258171, encodeId=6b2622581e1ba, content=偏重的研究方向：医学;综合 经验分享：SR投稿已有半年，目前已邀请超过10个审稿人，只有两个审稿人接受了审稿，然而还没有一个审稿人报告返回。太慢了吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28145445823, createdName=小计划, createdTime=Fri Mar 28 17:00:07 CST 2025, time=2025-03-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2233207, encodeId=1ba9223320e12, content=我八月份投了一篇孟德尔，因为没有交STROBE-MR被撤回了。之后补了表二次提交，已经进入同行评审了，收到邮件“It appears that you have already submitted your manuscript before to scientific reports and it was rejected for STROBE-MR checklist issue. I am sorry to inform you that we can not consider such manuscripts again. ”。因为第一次的问题导致第二次被撤回了？有没有什么补救办法呀，都送审了。求问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53b28427490, createdName=多多放辣, createdTime=Fri Oct 25 23:42:10 CST 2024, time=2024-10-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2257178, encodeId=2755225e1786d, content=投稿命中率:50.0 经验分享：我投的纯生信送审了，但是我想问一下审稿人拒掉的概率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed8e9545535, createdName=ms3000001858569369, createdTime=Fri Mar 21 21:35:43 CST 2025, time=2025-03-21, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2229336, encodeId=de44222933682, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：第一轮三个审稿人提了20多个问题，修稿完后又重新邀请审稿人，这次四个审稿人审稿，大家也是有这么多吗，还一轮一轮的审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37235317227, createdName=1489e359m96(暂无昵称), createdTime=Sat Oct 05 08:21:22 CST 2024, time=2024-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2249606, encodeId=d1222249606d5, content=2025中科院分区有可能降回3区吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58d55497410, createdName=慢热型选手, createdTime=Sat Jan 25 17:00:13 CST 2025, time=2025-01-25, status=1, ipAttribution=河北省)]

2025-03-30 tianjp506 来自北京

投稿7个月，一直在with editor，期间第一次催，态度极好，第7个月再催，拒稿，没有任何意见。太耽误时间了。

13 0

[GetPortalCommentsPageByObjectIdResponse(id=2260558, encodeId=0e452260558d2, content=投稿命中率:75.0 经验分享：二审5个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=075a9469484, createdName=ms2000001485045977, createdTime=Tue Apr 15 13:48:25 CST 2025, time=昨天, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2246458, encodeId=1f582246458f2, content=偏重的研究方向：临床 经验分享：投稿3个月被拒，投稿十天分配编辑，邀请审稿人三天后第一份意见收到，之后3个月一直等第二份审稿意见。最后，两个审稿人意见都很好，最后编辑给拒稿了。邮件末尾一看，编辑还是中国人，搞不懂为啥拒稿啊，意见都挺好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=142c9446281, createdName=ms4000002102138234, createdTime=Sat Jan 04 00:00:01 CST 2025, time=2025-01-04, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2259287, encodeId=111d225928ebf, content=审稿速度:6.0 偏重的研究方向：临床 经验分享：投稿5个月了，在2024年11月Reviewer report(s) received后就没有下文了，催了两次都没收到回复，大家催稿联系的是这个邮箱吗？srep@nature.com. Submission history Submission received Submission status Date Submission received 30 Oct 2024 Technical check Submission status Date Submission is under technical check 30 Oct 2024 Amendment requested 13 Nov 2024 Amendment received 13 Nov 2024 Amendment requested 14 Nov 2024 Amendment received 14 Nov 2024 Amendment requested 15 Nov 2024 Amendment received 15 Nov 2024 Submission passed technical check 15 Nov 2024 Editorial assignment Submission status Date Ready for editorial assignment 15 Nov 2024 With editor Submission status Date Editor assigned 25 Nov 2024 Peer review Submission status Date First reviewer(s) invited 25 Nov 2024 Reviewer(s) accepted 25 Nov 2024 Reviewer report(s) received 30 Nov 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0ef1674859, createdName=冰冷仙境, createdTime=Sat Apr 05 23:07:59 CST 2025, time=2025-04-05, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2257896, encodeId=f12c225e89678, content=偏重的研究方向：生信 经验分享：<a href='/topic/show?id=8aca1253863a' target=_blank style='color:#2F92EE;'>#NHANES数据库#</a> 3.1提交 3.6技术审核通过 3.6到现在已经过去20天，显示Ready for editorial assignment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=4, topicName=null, topicId=null, topicList=[TopicDto(id=125386, encryptionId=8aca1253863a, topicName=NHANES数据库)], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/ef17d3a0e1734e759d27ae31bfd577b4-6z81Fjps9u6c.jpeg, type=image, width=685, height=1410)], authenticateStatus=null, createdAvatar=null, createdBy=44a48378232, createdName=ms8000000780400336, createdTime=Wed Mar 26 23:42:08 CST 2025, time=2025-03-26, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2258357, encodeId=957a225835e35, content=投稿7个月，一直在with editor，期间第一次催，态度极好，第7个月再催，拒稿，没有任何意见。太耽误时间了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d171553686, createdName=tianjp506, createdTime=Sun Mar 30 10:50:28 CST 2025, time=2025-03-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2258171, encodeId=6b2622581e1ba, content=偏重的研究方向：医学;综合 经验分享：SR投稿已有半年，目前已邀请超过10个审稿人，只有两个审稿人接受了审稿，然而还没有一个审稿人报告返回。太慢了吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28145445823, createdName=小计划, createdTime=Fri Mar 28 17:00:07 CST 2025, time=2025-03-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2233207, encodeId=1ba9223320e12, content=我八月份投了一篇孟德尔，因为没有交STROBE-MR被撤回了。之后补了表二次提交，已经进入同行评审了，收到邮件“It appears that you have already submitted your manuscript before to scientific reports and it was rejected for STROBE-MR checklist issue. I am sorry to inform you that we can not consider such manuscripts again. ”。因为第一次的问题导致第二次被撤回了？有没有什么补救办法呀，都送审了。求问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53b28427490, createdName=多多放辣, createdTime=Fri Oct 25 23:42:10 CST 2024, time=2024-10-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2257178, encodeId=2755225e1786d, content=投稿命中率:50.0 经验分享：我投的纯生信送审了，但是我想问一下审稿人拒掉的概率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed8e9545535, createdName=ms3000001858569369, createdTime=Fri Mar 21 21:35:43 CST 2025, time=2025-03-21, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2229336, encodeId=de44222933682, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：第一轮三个审稿人提了20多个问题，修稿完后又重新邀请审稿人，这次四个审稿人审稿，大家也是有这么多吗，还一轮一轮的审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37235317227, createdName=1489e359m96(暂无昵称), createdTime=Sat Oct 05 08:21:22 CST 2024, time=2024-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2249606, encodeId=d1222249606d5, content=2025中科院分区有可能降回3区吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58d55497410, createdName=慢热型选手, createdTime=Sat Jan 25 17:00:13 CST 2025, time=2025-01-25, status=1, ipAttribution=河北省)]

2025-03-28 小计划来自山东省

偏重的研究方向：医学;综合
经验分享：SR投稿已有半年，目前已邀请超过10个审稿人，只有两个审稿人接受了审稿，然而还没有一个审稿人报告返回。太慢了吧！

8 0

[GetPortalCommentsPageByObjectIdResponse(id=2260558, encodeId=0e452260558d2, content=投稿命中率:75.0 经验分享：二审5个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=075a9469484, createdName=ms2000001485045977, createdTime=Tue Apr 15 13:48:25 CST 2025, time=昨天, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2246458, encodeId=1f582246458f2, content=偏重的研究方向：临床 经验分享：投稿3个月被拒，投稿十天分配编辑，邀请审稿人三天后第一份意见收到，之后3个月一直等第二份审稿意见。最后，两个审稿人意见都很好，最后编辑给拒稿了。邮件末尾一看，编辑还是中国人，搞不懂为啥拒稿啊，意见都挺好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=142c9446281, createdName=ms4000002102138234, createdTime=Sat Jan 04 00:00:01 CST 2025, time=2025-01-04, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2259287, encodeId=111d225928ebf, content=审稿速度:6.0 偏重的研究方向：临床 经验分享：投稿5个月了，在2024年11月Reviewer report(s) received后就没有下文了，催了两次都没收到回复，大家催稿联系的是这个邮箱吗？srep@nature.com. Submission history Submission received Submission status Date Submission received 30 Oct 2024 Technical check Submission status Date Submission is under technical check 30 Oct 2024 Amendment requested 13 Nov 2024 Amendment received 13 Nov 2024 Amendment requested 14 Nov 2024 Amendment received 14 Nov 2024 Amendment requested 15 Nov 2024 Amendment received 15 Nov 2024 Submission passed technical check 15 Nov 2024 Editorial assignment Submission status Date Ready for editorial assignment 15 Nov 2024 With editor Submission status Date Editor assigned 25 Nov 2024 Peer review Submission status Date First reviewer(s) invited 25 Nov 2024 Reviewer(s) accepted 25 Nov 2024 Reviewer report(s) received 30 Nov 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0ef1674859, createdName=冰冷仙境, createdTime=Sat Apr 05 23:07:59 CST 2025, time=2025-04-05, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2257896, encodeId=f12c225e89678, content=偏重的研究方向：生信 经验分享：<a href='/topic/show?id=8aca1253863a' target=_blank style='color:#2F92EE;'>#NHANES数据库#</a> 3.1提交 3.6技术审核通过 3.6到现在已经过去20天，显示Ready for editorial assignment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=4, topicName=null, topicId=null, topicList=[TopicDto(id=125386, encryptionId=8aca1253863a, topicName=NHANES数据库)], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/ef17d3a0e1734e759d27ae31bfd577b4-6z81Fjps9u6c.jpeg, type=image, width=685, height=1410)], authenticateStatus=null, createdAvatar=null, createdBy=44a48378232, createdName=ms8000000780400336, createdTime=Wed Mar 26 23:42:08 CST 2025, time=2025-03-26, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2258357, encodeId=957a225835e35, content=投稿7个月，一直在with editor，期间第一次催，态度极好，第7个月再催，拒稿，没有任何意见。太耽误时间了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d171553686, createdName=tianjp506, createdTime=Sun Mar 30 10:50:28 CST 2025, time=2025-03-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2258171, encodeId=6b2622581e1ba, content=偏重的研究方向：医学;综合 经验分享：SR投稿已有半年，目前已邀请超过10个审稿人，只有两个审稿人接受了审稿，然而还没有一个审稿人报告返回。太慢了吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28145445823, createdName=小计划, createdTime=Fri Mar 28 17:00:07 CST 2025, time=2025-03-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2233207, encodeId=1ba9223320e12, content=我八月份投了一篇孟德尔，因为没有交STROBE-MR被撤回了。之后补了表二次提交，已经进入同行评审了，收到邮件“It appears that you have already submitted your manuscript before to scientific reports and it was rejected for STROBE-MR checklist issue. I am sorry to inform you that we can not consider such manuscripts again. ”。因为第一次的问题导致第二次被撤回了？有没有什么补救办法呀，都送审了。求问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53b28427490, createdName=多多放辣, createdTime=Fri Oct 25 23:42:10 CST 2024, time=2024-10-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2257178, encodeId=2755225e1786d, content=投稿命中率:50.0 经验分享：我投的纯生信送审了，但是我想问一下审稿人拒掉的概率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed8e9545535, createdName=ms3000001858569369, createdTime=Fri Mar 21 21:35:43 CST 2025, time=2025-03-21, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2229336, encodeId=de44222933682, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：第一轮三个审稿人提了20多个问题，修稿完后又重新邀请审稿人，这次四个审稿人审稿，大家也是有这么多吗，还一轮一轮的审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37235317227, createdName=1489e359m96(暂无昵称), createdTime=Sat Oct 05 08:21:22 CST 2024, time=2024-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2249606, encodeId=d1222249606d5, content=2025中科院分区有可能降回3区吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58d55497410, createdName=慢热型选手, createdTime=Sat Jan 25 17:00:13 CST 2025, time=2025-01-25, status=1, ipAttribution=河北省)]

2024-10-25 多多放辣来自广东省

我八月份投了一篇孟德尔，因为没有交STROBE-MR被撤回了。之后补了表二次提交，已经进入同行评审了，收到邮件“It appears that you have already submitted your manuscript before to scientific reports and it was rejected for STROBE-MR checklist issue. I am sorry to inform you that we can not consider such manuscripts again. ”。因为第一次的问题导致第二次被撤回了？有没有什么补救办法呀，都送审了。求问

53 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=2260558, encodeId=0e452260558d2, content=投稿命中率:75.0 经验分享：二审5个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=075a9469484, createdName=ms2000001485045977, createdTime=Tue Apr 15 13:48:25 CST 2025, time=昨天, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2246458, encodeId=1f582246458f2, content=偏重的研究方向：临床 经验分享：投稿3个月被拒，投稿十天分配编辑，邀请审稿人三天后第一份意见收到，之后3个月一直等第二份审稿意见。最后，两个审稿人意见都很好，最后编辑给拒稿了。邮件末尾一看，编辑还是中国人，搞不懂为啥拒稿啊，意见都挺好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=142c9446281, createdName=ms4000002102138234, createdTime=Sat Jan 04 00:00:01 CST 2025, time=2025-01-04, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2259287, encodeId=111d225928ebf, content=审稿速度:6.0 偏重的研究方向：临床 经验分享：投稿5个月了，在2024年11月Reviewer report(s) received后就没有下文了，催了两次都没收到回复，大家催稿联系的是这个邮箱吗？srep@nature.com. Submission history Submission received Submission status Date Submission received 30 Oct 2024 Technical check Submission status Date Submission is under technical check 30 Oct 2024 Amendment requested 13 Nov 2024 Amendment received 13 Nov 2024 Amendment requested 14 Nov 2024 Amendment received 14 Nov 2024 Amendment requested 15 Nov 2024 Amendment received 15 Nov 2024 Submission passed technical check 15 Nov 2024 Editorial assignment Submission status Date Ready for editorial assignment 15 Nov 2024 With editor Submission status Date Editor assigned 25 Nov 2024 Peer review Submission status Date First reviewer(s) invited 25 Nov 2024 Reviewer(s) accepted 25 Nov 2024 Reviewer report(s) received 30 Nov 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0ef1674859, createdName=冰冷仙境, createdTime=Sat Apr 05 23:07:59 CST 2025, time=2025-04-05, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2257896, encodeId=f12c225e89678, content=偏重的研究方向：生信 经验分享：<a href='/topic/show?id=8aca1253863a' target=_blank style='color:#2F92EE;'>#NHANES数据库#</a> 3.1提交 3.6技术审核通过 3.6到现在已经过去20天，显示Ready for editorial assignment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=4, topicName=null, topicId=null, topicList=[TopicDto(id=125386, encryptionId=8aca1253863a, topicName=NHANES数据库)], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/ef17d3a0e1734e759d27ae31bfd577b4-6z81Fjps9u6c.jpeg, type=image, width=685, height=1410)], authenticateStatus=null, createdAvatar=null, createdBy=44a48378232, createdName=ms8000000780400336, createdTime=Wed Mar 26 23:42:08 CST 2025, time=2025-03-26, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2258357, encodeId=957a225835e35, content=投稿7个月，一直在with editor，期间第一次催，态度极好，第7个月再催，拒稿，没有任何意见。太耽误时间了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d171553686, createdName=tianjp506, createdTime=Sun Mar 30 10:50:28 CST 2025, time=2025-03-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2258171, encodeId=6b2622581e1ba, content=偏重的研究方向：医学;综合 经验分享：SR投稿已有半年，目前已邀请超过10个审稿人，只有两个审稿人接受了审稿，然而还没有一个审稿人报告返回。太慢了吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28145445823, createdName=小计划, createdTime=Fri Mar 28 17:00:07 CST 2025, time=2025-03-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2233207, encodeId=1ba9223320e12, content=我八月份投了一篇孟德尔，因为没有交STROBE-MR被撤回了。之后补了表二次提交，已经进入同行评审了，收到邮件“It appears that you have already submitted your manuscript before to scientific reports and it was rejected for STROBE-MR checklist issue. I am sorry to inform you that we can not consider such manuscripts again. ”。因为第一次的问题导致第二次被撤回了？有没有什么补救办法呀，都送审了。求问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53b28427490, createdName=多多放辣, createdTime=Fri Oct 25 23:42:10 CST 2024, time=2024-10-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2257178, encodeId=2755225e1786d, content=投稿命中率:50.0 经验分享：我投的纯生信送审了，但是我想问一下审稿人拒掉的概率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed8e9545535, createdName=ms3000001858569369, createdTime=Fri Mar 21 21:35:43 CST 2025, time=2025-03-21, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2229336, encodeId=de44222933682, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：第一轮三个审稿人提了20多个问题，修稿完后又重新邀请审稿人，这次四个审稿人审稿，大家也是有这么多吗，还一轮一轮的审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37235317227, createdName=1489e359m96(暂无昵称), createdTime=Sat Oct 05 08:21:22 CST 2024, time=2024-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2249606, encodeId=d1222249606d5, content=2025中科院分区有可能降回3区吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58d55497410, createdName=慢热型选手, createdTime=Sat Jan 25 17:00:13 CST 2025, time=2025-01-25, status=1, ipAttribution=河北省)]

2025-03-21 ms3000001858569369 来自新疆

投稿命中率:50.0
经验分享：我投的纯生信送审了，但是我想问一下审稿人拒掉的概率大吗

15 0

[GetPortalCommentsPageByObjectIdResponse(id=2260558, encodeId=0e452260558d2, content=投稿命中率:75.0 经验分享：二审5个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=075a9469484, createdName=ms2000001485045977, createdTime=Tue Apr 15 13:48:25 CST 2025, time=昨天, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2246458, encodeId=1f582246458f2, content=偏重的研究方向：临床 经验分享：投稿3个月被拒，投稿十天分配编辑，邀请审稿人三天后第一份意见收到，之后3个月一直等第二份审稿意见。最后，两个审稿人意见都很好，最后编辑给拒稿了。邮件末尾一看，编辑还是中国人，搞不懂为啥拒稿啊，意见都挺好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=142c9446281, createdName=ms4000002102138234, createdTime=Sat Jan 04 00:00:01 CST 2025, time=2025-01-04, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2259287, encodeId=111d225928ebf, content=审稿速度:6.0 偏重的研究方向：临床 经验分享：投稿5个月了，在2024年11月Reviewer report(s) received后就没有下文了，催了两次都没收到回复，大家催稿联系的是这个邮箱吗？srep@nature.com. Submission history Submission received Submission status Date Submission received 30 Oct 2024 Technical check Submission status Date Submission is under technical check 30 Oct 2024 Amendment requested 13 Nov 2024 Amendment received 13 Nov 2024 Amendment requested 14 Nov 2024 Amendment received 14 Nov 2024 Amendment requested 15 Nov 2024 Amendment received 15 Nov 2024 Submission passed technical check 15 Nov 2024 Editorial assignment Submission status Date Ready for editorial assignment 15 Nov 2024 With editor Submission status Date Editor assigned 25 Nov 2024 Peer review Submission status Date First reviewer(s) invited 25 Nov 2024 Reviewer(s) accepted 25 Nov 2024 Reviewer report(s) received 30 Nov 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0ef1674859, createdName=冰冷仙境, createdTime=Sat Apr 05 23:07:59 CST 2025, time=2025-04-05, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2257896, encodeId=f12c225e89678, content=偏重的研究方向：生信 经验分享：<a href='/topic/show?id=8aca1253863a' target=_blank style='color:#2F92EE;'>#NHANES数据库#</a> 3.1提交 3.6技术审核通过 3.6到现在已经过去20天，显示Ready for editorial assignment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=4, topicName=null, topicId=null, topicList=[TopicDto(id=125386, encryptionId=8aca1253863a, topicName=NHANES数据库)], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/ef17d3a0e1734e759d27ae31bfd577b4-6z81Fjps9u6c.jpeg, type=image, width=685, height=1410)], authenticateStatus=null, createdAvatar=null, createdBy=44a48378232, createdName=ms8000000780400336, createdTime=Wed Mar 26 23:42:08 CST 2025, time=2025-03-26, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2258357, encodeId=957a225835e35, content=投稿7个月，一直在with editor，期间第一次催，态度极好，第7个月再催，拒稿，没有任何意见。太耽误时间了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d171553686, createdName=tianjp506, createdTime=Sun Mar 30 10:50:28 CST 2025, time=2025-03-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2258171, encodeId=6b2622581e1ba, content=偏重的研究方向：医学;综合 经验分享：SR投稿已有半年，目前已邀请超过10个审稿人，只有两个审稿人接受了审稿，然而还没有一个审稿人报告返回。太慢了吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28145445823, createdName=小计划, createdTime=Fri Mar 28 17:00:07 CST 2025, time=2025-03-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2233207, encodeId=1ba9223320e12, content=我八月份投了一篇孟德尔，因为没有交STROBE-MR被撤回了。之后补了表二次提交，已经进入同行评审了，收到邮件“It appears that you have already submitted your manuscript before to scientific reports and it was rejected for STROBE-MR checklist issue. I am sorry to inform you that we can not consider such manuscripts again. ”。因为第一次的问题导致第二次被撤回了？有没有什么补救办法呀，都送审了。求问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53b28427490, createdName=多多放辣, createdTime=Fri Oct 25 23:42:10 CST 2024, time=2024-10-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2257178, encodeId=2755225e1786d, content=投稿命中率:50.0 经验分享：我投的纯生信送审了，但是我想问一下审稿人拒掉的概率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed8e9545535, createdName=ms3000001858569369, createdTime=Fri Mar 21 21:35:43 CST 2025, time=2025-03-21, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2229336, encodeId=de44222933682, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：第一轮三个审稿人提了20多个问题，修稿完后又重新邀请审稿人，这次四个审稿人审稿，大家也是有这么多吗，还一轮一轮的审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37235317227, createdName=1489e359m96(暂无昵称), createdTime=Sat Oct 05 08:21:22 CST 2024, time=2024-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2249606, encodeId=d1222249606d5, content=2025中科院分区有可能降回3区吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58d55497410, createdName=慢热型选手, createdTime=Sat Jan 25 17:00:13 CST 2025, time=2025-01-25, status=1, ipAttribution=河北省)]

2024-10-05 1489e359m96(暂无昵称) 来自广东省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：微生物
经验分享：第一轮三个审稿人提了20多个问题，修稿完后又重新邀请审稿人，这次四个审稿人审稿，大家也是有这么多吗，还一轮一轮的审稿

38 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2260558, encodeId=0e452260558d2, content=投稿命中率:75.0 经验分享：二审5个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=075a9469484, createdName=ms2000001485045977, createdTime=Tue Apr 15 13:48:25 CST 2025, time=昨天, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2246458, encodeId=1f582246458f2, content=偏重的研究方向：临床 经验分享：投稿3个月被拒，投稿十天分配编辑，邀请审稿人三天后第一份意见收到，之后3个月一直等第二份审稿意见。最后，两个审稿人意见都很好，最后编辑给拒稿了。邮件末尾一看，编辑还是中国人，搞不懂为啥拒稿啊，意见都挺好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=142c9446281, createdName=ms4000002102138234, createdTime=Sat Jan 04 00:00:01 CST 2025, time=2025-01-04, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2259287, encodeId=111d225928ebf, content=审稿速度:6.0 偏重的研究方向：临床 经验分享：投稿5个月了，在2024年11月Reviewer report(s) received后就没有下文了，催了两次都没收到回复，大家催稿联系的是这个邮箱吗？srep@nature.com. Submission history Submission received Submission status Date Submission received 30 Oct 2024 Technical check Submission status Date Submission is under technical check 30 Oct 2024 Amendment requested 13 Nov 2024 Amendment received 13 Nov 2024 Amendment requested 14 Nov 2024 Amendment received 14 Nov 2024 Amendment requested 15 Nov 2024 Amendment received 15 Nov 2024 Submission passed technical check 15 Nov 2024 Editorial assignment Submission status Date Ready for editorial assignment 15 Nov 2024 With editor Submission status Date Editor assigned 25 Nov 2024 Peer review Submission status Date First reviewer(s) invited 25 Nov 2024 Reviewer(s) accepted 25 Nov 2024 Reviewer report(s) received 30 Nov 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0ef1674859, createdName=冰冷仙境, createdTime=Sat Apr 05 23:07:59 CST 2025, time=2025-04-05, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2257896, encodeId=f12c225e89678, content=偏重的研究方向：生信 经验分享：<a href='/topic/show?id=8aca1253863a' target=_blank style='color:#2F92EE;'>#NHANES数据库#</a> 3.1提交 3.6技术审核通过 3.6到现在已经过去20天，显示Ready for editorial assignment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=4, topicName=null, topicId=null, topicList=[TopicDto(id=125386, encryptionId=8aca1253863a, topicName=NHANES数据库)], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/ef17d3a0e1734e759d27ae31bfd577b4-6z81Fjps9u6c.jpeg, type=image, width=685, height=1410)], authenticateStatus=null, createdAvatar=null, createdBy=44a48378232, createdName=ms8000000780400336, createdTime=Wed Mar 26 23:42:08 CST 2025, time=2025-03-26, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2258357, encodeId=957a225835e35, content=投稿7个月，一直在with editor，期间第一次催，态度极好，第7个月再催，拒稿，没有任何意见。太耽误时间了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d171553686, createdName=tianjp506, createdTime=Sun Mar 30 10:50:28 CST 2025, time=2025-03-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2258171, encodeId=6b2622581e1ba, content=偏重的研究方向：医学;综合 经验分享：SR投稿已有半年，目前已邀请超过10个审稿人，只有两个审稿人接受了审稿，然而还没有一个审稿人报告返回。太慢了吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28145445823, createdName=小计划, createdTime=Fri Mar 28 17:00:07 CST 2025, time=2025-03-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2233207, encodeId=1ba9223320e12, content=我八月份投了一篇孟德尔，因为没有交STROBE-MR被撤回了。之后补了表二次提交，已经进入同行评审了，收到邮件“It appears that you have already submitted your manuscript before to scientific reports and it was rejected for STROBE-MR checklist issue. I am sorry to inform you that we can not consider such manuscripts again. ”。因为第一次的问题导致第二次被撤回了？有没有什么补救办法呀，都送审了。求问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53b28427490, createdName=多多放辣, createdTime=Fri Oct 25 23:42:10 CST 2024, time=2024-10-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2257178, encodeId=2755225e1786d, content=投稿命中率:50.0 经验分享：我投的纯生信送审了，但是我想问一下审稿人拒掉的概率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed8e9545535, createdName=ms3000001858569369, createdTime=Fri Mar 21 21:35:43 CST 2025, time=2025-03-21, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2229336, encodeId=de44222933682, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：第一轮三个审稿人提了20多个问题，修稿完后又重新邀请审稿人，这次四个审稿人审稿，大家也是有这么多吗，还一轮一轮的审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37235317227, createdName=1489e359m96(暂无昵称), createdTime=Sat Oct 05 08:21:22 CST 2024, time=2024-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2249606, encodeId=d1222249606d5, content=2025中科院分区有可能降回3区吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58d55497410, createdName=慢热型选手, createdTime=Sat Jan 25 17:00:13 CST 2025, time=2025-01-25, status=1, ipAttribution=河北省)]

2025-01-25 慢热型选手来自河北省

2025中科院分区有可能降回3区吗？

30 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务